International Myeloma Foundation and Black Swan Research Initiative Announce the Release of New IStopMM Cohort Study: A Multivariable Prediction Model for Bone Marrow Sampling on Individuals With MGUS
April 12, 2024
April 12, 2024
STUDIO CITY, California, April 12 (TNSres) -- The International Myeloma Foundation issued the following news:
The International Myeloma Foundation (IMF) and Black Swan Research Initiative(R) (BSRI) announced the recently published cohort study by the iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) team on the "Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons with Monoclonal Gammopathy of Undetermined Significance (MGUS . . .
The International Myeloma Foundation (IMF) and Black Swan Research Initiative(R) (BSRI) announced the recently published cohort study by the iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) team on the "Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons with Monoclonal Gammopathy of Undetermined Significance (MGUS . . .